Gsa Capital Partners LLP Prime Medicine, Inc. Transaction History
Gsa Capital Partners LLP
- $1.32 Billion
- Q3 2024
A detailed history of Gsa Capital Partners LLP transactions in Prime Medicine, Inc. stock. As of the latest transaction made, Gsa Capital Partners LLP holds 99,060 shares of PRME stock, worth $287,274. This represents 0.03% of its overall portfolio holdings.
Number of Shares
99,060Holding current value
$287,274% of portfolio
0.03%Shares
2 transactions
Others Institutions Holding PRME
# of Institutions
123Shares Held
64.7MCall Options Held
324KPut Options Held
64.4K-
Alphabet Inc. Mountain View, CA15.1MShares$43.7 Million3.99% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl5.66MShares$16.4 Million0.21% of portfolio
-
Black Rock Inc. New York, NY5.11MShares$14.8 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.89MShares$14.2 Million0.0% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD3.81MShares$11 Million0.01% of portfolio
About Prime Medicine, Inc.
- Ticker PRME
- Shares Outstandng 95,730,200
- Market Cap $278M